The Patent Finder

Aventisub LLC

Also on record
Records under this name other than the patents Aventisub LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 20 patents it holds.

Back to Aventisub LLC

PatentTitleStatus Expires Confidence
US 8,899,419Package with Break-Away Clamshell
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,919,559Package with Break-Away Clamshell
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,130,620Liquid pharmaceutical composition for oral administration comprising fexofenadine
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 6,794,410Use of (Z) -2-Cyano-3-Hydroxy-BUT-2-Enoic ACID-(4' -Trifluoromethylphenyl)-Amide for Treating Multiple Sclerosis
Term ended
Term ended Sep 26, 2026 · High confidence
Term endedTerm ended Sep 26, 2026High confidence
US 7,618,650Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof
Term ended
Ended no later than Aug 16, 2026 · From the USPTO record
Term endedEnded no later than Aug 16, 2026From the USPTO record
US 7,402,672Substituted 1H-PYRROLO[3,2-B, 3,2-C, and 2,3-C]PYRIDINE-2-Carboxamides and Related Analogs as Inhibitors of Casein Kinase Lepsilon
Term ended
Term ended Apr 12, 2026 · High confidence
Term endedTerm ended Apr 12, 2026High confidence
US 7,625,889Substituted bis aryl and heteroaryl compounds as selective 5HT2A antagonists
Term ended
Term ended Feb 10, 2026 · From the USPTO record
Term endedTerm ended Feb 10, 2026From the USPTO record
US 7,923,4663-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase I
Term ended
Term ended Feb 3, 2026 · From the USPTO record
Term endedTerm ended Feb 3, 2026From the USPTO record
US 7,629,3763-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase I
Term ended
Term ended Jan 24, 2026 · From the USPTO record
Term endedTerm ended Jan 24, 2026From the USPTO record
US 7,538,106Application of 2-Cyano-10- (2-Methyl-3- (METHYLAMINO)- Propyl) Phenothiazine or a Pharmaceutically Acceptable Salt as Medicament
Term ended
Term ended Nov 21, 2025 · High confidence
Term endedTerm ended Nov 21, 2025High confidence
10 of 251 patents shown.
Pro members see all 251.
Pro members: see all 251 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited